A61K 38 - Medicinal preparations containing peptides

Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
12/2009
12/31/2009	US20090324719 Extracellular matrix composition
12/31/2009	US20090324707 Method for synthesizing conformationally constrained peptides, peptidomimetics and the use thereof as synthetic vaccines
12/31/2009	US20090324705 Phytonutrient compositions for topical use
12/31/2009	US20090324701 Compositions containing (s)-bethanechol and their use in the treatment of insulin resistance, type 2 diabetes, glucose intolerance and related disorders
12/31/2009	US20090324700 Methods and compositions for the inhibition of cathepsins
12/31/2009	US20090324685 Medical device coatings containing charged materials
12/31/2009	US20090324677 Polymer conjugates of box-a of hmgb1 and box-a variants of hmgb1
12/31/2009	US20090324669 Osteogenic enhancer composition
12/31/2009	US20090324646 Targeting the Histone Code as a Bacterial Strategy for Selectively Modulating Gene Expression
12/31/2009	US20090324639 Compositions and methods for activating innate and allergic immunity
12/31/2009	US20090324635 Caspofungin free of caspofungin impurity A
12/31/2009	US20090324633 Immunogens from Uropathogenic Escherichia Coli
12/31/2009	US20090324632 Methods and reagents for vaccination which generate a CD8 T cell immune response
12/31/2009	US20090324631 Polyvalent Vaccine
12/31/2009	US20090324627 ISOLATED DNA DIRECTED 50kD REGULATORY SUBUNIT (POLD2) GENOMIC POLYNUCLEOTIDE FRAGMENTS FROM CHOMOSOME 7 AND THEIR USES
12/31/2009	US20090324626 Isolated snare ykt6 genomic polynucleotide fragments from chomosome 7 and their uses
12/31/2009	US20090324620 Conjugates of therapeutic or cytotoxic agents and biologically active peptides
12/31/2009	US20090324612 Modulating neuronal outgrowth via the major histocompatibility complex class i (mhc i) molecule
12/31/2009	US20090324611 Targeting VEGF-B Regulation Of Fatty Acid Transporters To Modulate Human Diseases
12/31/2009	US20090324608 Novel human protein kinase, phosphatase, and protease family members and uses thereof
12/31/2009	US20090324599 activates FGF receptors, regulates the growth and differentiation of cells within the liver, regulates other cell types following secretion from the liver, plays a role in liver chemotaxis, has an oncogenic activity, or serves as an antigen for generating antibodies; treating diabetes or obesity
12/31/2009	US20090324597 Unique long 16 (UL-16)-binding proteins (ULBP) specific immunoglobulin for use in diganosis cell proliferative disorders
12/31/2009	US20090324592 Compositions and methods for the diagnosis and treatment of tumor
12/31/2009	US20090324590 Myostatin antagonists
12/31/2009	US20090324586 Lyophilization cycle robustness strategy
12/31/2009	US20090324585 Complement inhibitory agents as therapeutics in posttraumatic and degenerative arthritis
12/31/2009	US20090324584 Nucleic Acid of Formula (I): GIXmGn, or (II): CIXmCn, in Particular as an Immune-Stimulating Agent/Adjuvant
12/31/2009	US20090324576 Phage derived antimicrobial activities
12/31/2009	US20090324575 Lysosomal phospholipase a2 (lpla2) activity as a diagnostic and therapeutic target for identifying and treating systemic lupus erythematosis
12/31/2009	US20090324574 Esterases and Related Nucleic Acids and Methods
12/31/2009	US20090324573 Pharmaceutical Composition Comprising P43 Protein for the Treatment of Gastric Adenocarcinoma
12/31/2009	US20090324572 Methods and compositions for the treatment of symptoms of williams syndrome
12/31/2009	US20090324571 Use of bacterial amylases in feed for bovine animals
12/31/2009	US20090324568 Colonic Delivery of Adsorbents
12/31/2009	US20090324562 Defensin Proteins
12/31/2009	US20090324558 Transdiscal administration of cycline compounds
12/31/2009	US20090324556 Mutated immunogenic peptides derived from R9M, polynucleotides coding for same and therapeutic uses thereof
12/31/2009	US20090324553 Chimeric Viral Envelopes
12/31/2009	US20090324549 Proteins and/or peptides for the prevention and/or treatment of neurodegenerative diseases
12/31/2009	US20090324545 Polymorphic forms of (s)-1-tetrahydrofuran-3-yl-3-(3-(3-methoxy-4-(oxazol-5-yl)phenyl)ureido)benzyl carbamate
12/31/2009	US20090324544 Substituted cyclic pyrrolidine derivatives
12/31/2009	US20090324543 PYRIDO(3,2-d)PYRIMIDINES USEFUL FOR TREATING VIRAL INFECTIONS
12/31/2009	US20090324542 optic neuritis; fingolimod or 2-amino-2-{2-[4-(1-oxo-5-phenylpentyl)phenyl]ethyl}propane-1,3-diol or salts as SP1 agonist
12/31/2009	US20090324541 Prophylactic or therapeutic agent for viral disease
12/31/2009	US20090324540 Compounds and compositions for delivering active agents
12/31/2009	US20090324539 CANCER TREATMENT COMBINING LYMPHODEPLETING AGENT WITH CTLs AND CYTOKINES
12/31/2009	US20090324538 Fusion molecules and IL-15 variants
12/31/2009	US20090324535 Modified macromolecule
12/31/2009	US20090324518 Novel Compositions Against Alkyl-Acyul-GPC The Derivatitves and Products Thereof
12/31/2009	US20090324502 Nasal Formulations of Insulin
12/31/2009	US20090324495 Compounds and methods for enzyme-mediated tumor imaging and therapy
12/31/2009	US20090324494 Magnetic nano-composite for contrast agent, intelligent contrast agent, drug delivery agent for simultaneous diagnosis and treatment, and separation agent for target substance
12/31/2009	US20090324492 Treatment for Central Nervous System Disorders
12/31/2009	US20090324490 Compositions and methods for the diagnosis and treatment of tumor
12/31/2009	DE102008030764A1 Kombination von Amidin-Derivaten mit cyclischen Depsipeptiden Combination of amidine derivatives with cyclic depsipeptides
12/30/2009	WO2009158704A2 Therapeutic agents comprising elastin-like peptides
12/30/2009	WO2009158696A1 SOLUBLE HYBRID Fcγ RECEPTORS AND RELATED METHODS
12/30/2009	WO2009158633A1 Drug conjugates
12/30/2009	WO2009158620A2 Signatures and determinants associated with metastasis methods of use thereof
12/30/2009	WO2009158563A1 Method for treating or preventing radiation damage by in vivo gene therapy
12/30/2009	WO2009158529A2 Lyophilization cycle robustness strategy
12/30/2009	WO2009158480A2 Stimulation of cartilage formation using reduced pressure treatment
12/30/2009	WO2009158415A1 Octreotide implant having a release agent
12/30/2009	WO2009158412A2 Sustained delivery of exenatide and other polypeptides
12/30/2009	WO2009158409A2 Pimap39 modulates inflammatory response
12/30/2009	WO2009158284A2 Methods and materials for producing immune responses against polypeptides involved in antibiotic resistance
12/30/2009	WO2009158238A2 Fibroblast growth factor (fgf) analogs and uses thereof
12/30/2009	WO2009158035A2 Methods for dosing an activin-actriia antagonist and monitoring of treated patients
12/30/2009	WO2009158033A2 Antagonists of activin-actriia and uses for increasing red blood cell levels
12/30/2009	WO2009158025A2 Methods for dosing an actriib antagonist and monitoring of treated patients
12/30/2009	WO2009158015A2 Antagonists of actriib and uses for increasing red blood cell levels
12/30/2009	WO2009158007A2 Methods and compositions for therapeutic treatment
12/30/2009	WO2009157926A1 Chloramphenicol acetyl transferase (cat)-defective somatostatin fusion protein and uses thereof
12/30/2009	WO2009157919A1 SOLUBLE ErbB3 DETECTION, REGULATION AND TREATMENT OF CANCER
12/30/2009	WO2009157869A1 Enamel matrix derivative fraction c
12/30/2009	WO2009157767A1 Nutritional composition for improving the mammalian immune system
12/30/2009	WO2009157759A1 Nutritional composition for improving the mammalian immune system
12/30/2009	WO2009157013A1 Protein based product from fenugreek seeds that regulates dyslipidemia and obesity, and a process for the preparation thereof
12/30/2009	WO2009157010A1 An intravenous drug delivery system
12/30/2009	WO2009156544A1 Complexes of albumin with omega-9 monounsaturated fatty acids for treatment of medullary lesions
12/30/2009	WO2009156473A1 Derivatised hybrid peptides of amylin and salmon calcitonin
12/30/2009	WO2009156172A1 System for the determination of molecules altering the function of interferon, method therefor and compounds altering interferon activity
12/30/2009	WO2009156137A1 Factor viii, von willebrand factor or complexes thereof with prolonged in vivo half-life
12/30/2009	WO2009156071A1 Combination of amidine derivates with cyclic depsipeptides
12/30/2009	WO2009155936A1 Use of hsp70 as a regulator of enzymatic activity
12/30/2009	WO2009155932A2 Modulation of the trpv : vps10p-domain receptor system for the treatment of pain
12/30/2009	WO2009155842A1 Fusion protein of onconase and toxin transmembrane domain and preparation method and use thereof
12/30/2009	WO2009155789A1 Polypeptides and derivatives thereof that inhibit hiv infection
12/30/2009	WO2009155709A1 Bridged secondary amines and use thereof as iap bir domain binding compounds
12/30/2009	WO2009155705A1 Polysaccharide-protein conjugates reversibly coupled via imine bonds
12/30/2009	WO2009155689A1 Nitric oxide device and method for wound healing, treatment of dermatological disorders and microbial infections
12/30/2009	WO2009155678A1 Therapeutic proteins from latex
12/30/2009	WO2009155669A1 Method of treatment of vascular complications
12/30/2009	WO2009155659A1 Combination therapy
12/30/2009	WO2009155637A1 Protocols for treating and preventing obesity and complications arising therefrom
12/30/2009	WO2009139855A3 Pharmaceutical compositions of somatostatin-dopamine conjugates
12/30/2009	WO2009136173A3 Biomimetic cell scaffolds
12/30/2009	WO2009135165A3 Small humanin-like peptides
12/30/2009	WO2009134380A3 Super fast-acting insulin compositions
12/30/2009	WO2009126346A3 Methods for prevention and treatment of infections with supraphysiological doses of mannan-binding lectin (mbl) and ficolin-mbl fusion proteins

1 ... 688 689 690 691 692 693 694 695 696 697 698 699 700 701 702 703 704 705 706 707 708 ... 3163